| Ansøgningsnr. og dato | 15821589.7 (espacenet) (Federated) (European Patent Register), 20150716 | | Patent/reg.nr. og dato | DK/EP 3169345, 20250129 | | Tilgængelighedsdato | 20170524 | | Prioritetsnr. og dato | US 201462025737 P, 20140717 | | EP publ. nr. og dato |
EP 3169345 20170524 | | Løbedag | | | Ansøger/indehaver | Melinta Therapeutics, LLC, 389 Interpace Parkway
Suite 450
Parsippany, NJ 07054, US | | Ansøgers ref. nr. | | | Opfinder | RAFAI FAR, Adel, 2170 Hanover Road
Mount-Royal, Québec H3R 2X8, CA,
KRISHNA, Gopal, c/o The Medicines Company
8 Sylvan Way
Parsippany, New Jersey 07054, US,
DING, Min, c/o The Medicines Company
8 Sylvan Way
Parsippany, New Jersey 07054, US,
CHEMBURKAR, Sanjay R., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US,
KNABLE, Carl M., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US,
PRUYNE, Julie J., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US,
REAMER, Douglas M., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US,
PETZEL, James P., c/o AbbVie Inc.
1 North Waukegan Road
Building AP-34-2
North Chicago, Illinois 60064, US | | Fuldmægtig | | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/7052 (2006.01) , A61K 38/14 (2006.01) , A61K 47/26 (2006.01) , A61K 47/30 (2006.01) , A61K 47/36 (2006.01) , A61K 9/19 (2006.01) , A61P 31/04 (2006.01) , C07K 9/00 (2006.01) , C12P 21/02 (2006.01) | | Titel/benævnelse | HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME | | Internationalt ansøgningsnr. | US2015040736 | | Internationalt publ. nr. | WO2016011245 | | Relateret sag (certifikat) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
